Slides
For the best viewing experience, make sure that you access MELODEM via this website (it should have “sites” in the URL): https://sites.bu.edu/melodem/
2023
September 21st, 2023: Dr. Suzanne Judd, professor in the School of Public Health at the University of Alabama at Birmingham. Dr. Judd will be introducing us to two amazing cohort studies on which she is a PI: REGARDS and RURAL. Her research focuses on racial and regional differences in brain health with a particular focus on nutritional drivers of differences.
Suzanne Judd, Cognitive Impairments in REGARDS
May 4th, 2023: Elizabeth Rose Mayeda, University of California, Los Angeles, Fielding School of Public Health will be presenting on “How much does amyloid burden predict memory decline at the population level? A transportability analysis.”
April 20th, 2023: Jennifer J. Manly, Department of Neurology and the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia University, “Methods for Estimating National Prevalence of Dementia and MCI from the Harmonized Cognitive Assessment Protocol Project.”
April 6th, 2023: Maude Wagner, BPH Research Center, Bordeaux University, “Using Longitudinal Continuous Measures to Capture Key Complementary Dimensions of Cognitive Resilience to AD Neuropathology”
March 16th, 2023: Roch A. Nianogo, Fielding School of Public Health, UCLA, “Risk Factors Associated with Alzheimer Disease and Related Dementias by Sex and Race and Ethnicity in the US”
March 2nd, 2023: Lon S. Schneider, Keck School of Medicine of USC, “Lecanemab: effectiveness, approval, and why it takes a village”
February 16th, 2023: Terry M Therneau, Department of Quantitative Health Sciences, Mayo Clinic, “Competing risks and the Fine-Gray model”
February 2nd, 2023: Erin E. Bennett, The George Washington University Milken Institute School of Public Health, “Methodological considerations in target trial emulation using cohort studies: estimating the effect of antihypertensive medication initiation on incident dementia in ARIC, CHS, and HRS”
January 19th, 2023: Marina Sirota, Bakar Computational Health Sciences Institute, UCSF, “Leveraging Molecular and Clinical Data to Better Understand Alzheimer’s Disease”
2022
December 15th, 2022: Sepideh Modrek, San Francisco State University, Health Equity Institute & David Rehkopf, Stanford University, “Long-term effects of Local Area New Deal Work-Relief in Childhood on Educational and Cognitive Outcomes over the Life Course”
Sepideh Modrek & David Rehkopf
December 1, 2022: Tara E. Jenson, Zilber School of Public Health, University of Wisconsin – Milwaukee, “Environmental Cadmium Exposures, Cognitive Performance in Older Adults, and Subsequent Alzheimer’s Disease Mortality.”
November 3, 2022: Tianhao Wang, Rush Alzheimer’s Disease Center, Rush University Medical Center, “The ‘cognitive clock’: A novel indicator of brain health”
October 20, 2022: Emma Nichols, Johns Hopkins Bloomberg School of Public Health, “The use of algorithms for the identification of incident dementia: challenges and potential biases:
October 6, 2022: John (Rob) Warren, Minnesota Population Center, University of Minnesota “High School & Beyond: Turning an Education Cohort Study into an ADRD Study.”
September 15, 2022: Marcia P Jimenez, Boston University & L. Paloma Rojas-Saunero, UCLA “Racial and ethnic differences in the risk of dementia under hypothetical blood-pressure-lowering interventions: The Multi-Ethnic Study of Atherosclerosis.”
Marcia P Jimenez & L. Paloma Rojas-Saunero
2021
November 18, 2021: Madhav Thambisetty, NIA/NIH, “From Mechanisms to Medicines: realizing the DREAM of an Alzheimer’s cure.”
October 28, 2021: Venexia Walker, University of Bristol, “Predicting drug repurposing opportunities for Alzheimer’s disease prevention using genome-wide association study data”
October 8, 2021: Maria Glymous, UCSF, “Introduction to using Directed Acyclic Graphs in dementia research”
September 15, 2021: Ryan Andrews, Boston University School of Public Health, “Meditations on Mediation Analysis”
September 2, 2021: Michelle Odden, Stanford University, “Collider Stratification Bias in Studies of Dementia: Mountain or Molehill?”
July 15, 2021: Thomas Nedelec, Paris Brain Institute, “Data-driven identification of health conditions associated with incident Alzheimer’s disease dementia risk: a 15 years follow-up cohort from electronic health records in France and the United Kingdom”
June 3, 2021: L. Paloma Rojas-Saunero, Erasmus MC, “Dissecting the causal question underlying the association between cancer and dementia”
April 1, 2021: Zach Baucom, Boston University School of Public Health, “Using State Space Models for Longitudinal Neuropsychological Outcomes”
March 18, 2021: Lon Schneider, University of Southern California, “Methodological features and FDA’s regulatory guidance on aducanumab and Alzheimer drug development”
2020
October 15, 2020: Deborah Blacker & Sudeshna Seshadri, Harvard Medical School/Massachusetts General Hospital, “Towards Real-World Data for Dementia Studies: Use of machine-learning to improve metrics”
Sudeshna Seshadri & Deborah Blacker
July 9, 2020: Bryan James, Rush Alzheimer’s Disease Center, “Implications of covid for dementia researchers”
May 7, 2020: Jonathan Jackson, Harvard Medical School/Massachusetts General Hospital, “The Challenge of Health Equity in Clinical Research: Towards a Quantifiable Science of Inclusion.”